William Ratner

William Ratner is a seasoned professional in the pharmaceutical industry with over 25 years of experience. Currently serving as Vice President of US Migraine at AbbVie since July 2017, William leads marketing and sales efforts for the migraine treatments Qulipta and Ubrelvy. Prior to AbbVie, William spent nearly two decades at Eli Lilly and Company in various roles, including Vice President of US Dermatology and Senior Director for multiple therapeutic areas such as Headache and Pain, Rheumatology, and Neuroscience. William received an MBA in Marketing and a Pharm.D. in Pharmacy from the University of Florida.